Hovione Cork renews its certification of The Business Working Responsibly Mark
A recognition for CSR practices at the site and its positive impact on both the workplace and the wider community
Pharma's Almanac, 26 October, 2018
Although the majority of new drug candidates suffer from poor solubility and bioavailability, oral solid dosage forms remain the preferred route of administration due to their ease of use and convenience for patients and caregivers. In recent years, numerous drugs formulated as amorphous solid dispersions (ASDs) have been successfully commercialized, confirming the effectiveness of these technologies for enhancing the dissolution of challenging APIs.
Topics covered in the article:
Addressing Solubility Issues
Benefits of ASDs
Two Leading ASD Technologies
Maintaining the Metastable Form
Facilitating ASD Development and Manufacturing
Greater Understanding for Rational Design
A recognition for CSR practices at the site and its positive impact on both the workplace and the wider community
Mrs. Diane Villax represented Hovione at the Gala of the Order of Engineers
Procurement Leaders invited our Procurement Director to explain how Hovione produced and offered sanitizing agent to the community.
This expansion in New Jersey will create up to 100 jobs over the next few years is part of a global expansion strategy